Auna S.A. (AUNA)
Automate Your Wheel Strategy on AUNA
With Tiblio's Option Bot, you can configure your own wheel strategy including AUNA - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol AUNA
- Rev/Share 59.133
- Book/Share 21.8806
- PB 1.1312
- Debt/Equity 2.5505
- CurrentRatio 0.8761
- ROIC 0.091
- MktCap 1667403324.5652
- FreeCF/Share 7.3173
- PFCF 3.0721
- PE 14.8787
- Debt/Assets 0.5321
- DivYield 0
- ROE 0.0734
- Rating B+
- Score 3
- Recommendation Neutral
- P/E Score 2
- DCF Score 4
- P/B Score 4
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Downgrade | AUNA | HSBC Securities | Buy | Hold | -- | $7.9 | May 22, 2025 |
News
Auna: Scalable, Profitable, Misunderstood
Published: June 23, 2025 by: Seeking Alpha
Sentiment: Positive
AUNA's integrated LatAm healthcare platform is undervalued due to short-term execution, not structural flaws. The payor-provider model drives superior margins, cost efficiencies, and creates a powerful ecosystem with strong operating leverage, especially in underutilized Mexican assets. Management is actively addressing physician onboarding and payor mix, with insurance-led strategies poised to drive patient volume and profitability recovery.
Read More
Auna S.A. (AUNA) Q1 Earnings Top Estimates
Published: May 20, 2025 by: Zacks Investment Research
Sentiment: Positive
Auna S.A. (AUNA) came out with quarterly earnings of $0.19 per share, beating the Zacks Consensus Estimate of $0.10 per share. This compares to earnings of $0.10 per share a year ago.
Read More
Auna S.A. (AUNA) Reports Next Week: What You Should Expect
Published: May 13, 2025 by: Zacks Investment Research
Sentiment: Neutral
Auna S.A. (AUNA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Read More
Auna: Strong Q4, Execution In Mexico Will Be Key, Reiterating Buy
Published: April 10, 2025 by: Seeking Alpha
Sentiment: Positive
Auna achieved strong 2024 results with 11% revenue growth and 20% EBITDA growth, driven by successful operations in Peru and expansion efforts in Mexico. Mexico's market potential is significant, with strategic partnerships and a focus on oncologic plans, while Colombia faces regulatory challenges impacting profitability. The company is focused on deleveraging, aiming for a leverage ratio below 3X by 2025, driven by a projected 20% EBITDA growth.
Read More
Are Medical Stocks Lagging Auna S.A. (AUNA) This Year?
Published: March 27, 2025 by: Zacks Investment Research
Sentiment: Negative
Here is how Auna S.A. (AUNA) and Coya Therapeutics, Inc. (COYA) have performed compared to their sector so far this year.
Read More
Is Auna S.A. (AUNA) Stock Outpacing Its Medical Peers This Year?
Published: March 03, 2025 by: Zacks Investment Research
Sentiment: Positive
Here is how Auna S.A. (AUNA) and BioMarin Pharmaceutical (BMRN) have performed compared to their sector so far this year.
Read More
Wall Street Analysts Predict a 39.33% Upside in Auna S.A. (AUNA): Here's What You Should Know
Published: February 14, 2025 by: Zacks Investment Research
Sentiment: Positive
The mean of analysts' price targets for Auna S.A. (AUNA) points to a 39.3% upside in the stock.
Read More
About Auna S.A. (AUNA)
- IPO Date
- Website https://aunainvestors.com/English
- Industry Medical - Care Facilities
- CEO Jesús Antonio Zamora Leon
- Employees 14605